Current Report Filing (8-k)
January 03 2019 - 06:09AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
January 2, 2019
Date of Report (Date of earliest event reported)
GALA PHARMACEUTICAL INC.
(Exact name of registrant as specified in
its charter)
NEVADA
|
000-52044
|
42-1771014
|
(State or other jurisdiction of
|
(Commission File
|
(IRS Employer Identification No.)
|
incorporation)
|
Number)
|
|
|
|
|
18881 Von Karman Avenue, Suite 1440, Irvine, California
|
92612
|
(Address of principal executive offices)
|
(Zip Code)
|
(949) 851-9261
Registrant's telephone number, including area code
(Former name or former address, if changed
since last report)
Check the appropriate box below if the Form
8-K fi ling is intended to simultaneously satisfy the fi ling obligation of the registrant under any of the following provisions
(see General Instruction A.2. below):
[ ] Written communications pursuant to Rule
425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant
to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
[ ]
If an emerging growth company, indicate by
check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
|
ITEM 5.02.
|
DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS
|
On
December 31, 2018, Mr.
Reiner Hoogenraad
,
was appointed as a member of the Company’s Board of Directors.
His biography is set
forth below:
Reiner Hoogenraad,
is the President
of American Custom Golf Cars, Inc., a business started over 25 years ago (also known as ACG, Inc.). Mr. Hoogenraad was born in
1959 in Holland and graduated from Maerland Lyceum in Holland.
Mr. Hoogenraad began his career in the automotive
industry in 1980. He has been a successful entrepreneur for over 30 years, and has 20 years’ experience as an Internal Combustion
Engine and Electric Vehicle designer/developer including: car suspension development (later used by the Shelby Ultimate Aero supercar);
drive train engineering and assembly; electric motor design and modification; automotive parts procurement; and vehicle assembly
line and factory developer and owner. He is both a sole and multiple current automotive patent holder.
Signatures
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
|
|
|
Date: January 2, 2019
|
By:
|
/s/ Maqsood Rehman
|
|
|
Maqsood Rehman
|
|
Title:
|
Chief Executive Officer
|